
Evaluating the Rapidly Changing ADC Landscape in HR+/HER2– Breast Cancer
During a CancerNetwork-hosted Satellite Sessions program at the University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center, a panel of experts discussed the role of antibody-drug conjugates (ADCs) in triple-negative breast cancer and hormone …